| Detailed information |
|---|
| CancerLivER ID | 2119 |
| Biomarker | KIAA1114 |
| Biomarker Name/Symbol (given in Publication) | KIAA1114 |
| Biomolecule | Protein |
| Subject | Human and Mice cell lines |
| Degree of Validity | KIAA1114, as a potential diagnostic factor of human liver cancer, but also as an independent biomarker for identifying TIC (tumor initiating cells) populations that could be broadly applied to the heterogeneous HCC subtypes and validated on independent dataset |
| Experimental Condition | Normal cell line vs HCC cell line |
| Cancer type | Hepatocellular carcinoma, Cholangiocarcinoma |
| Regulation | KIAA1114 is overexpressed in human liver cancer cell lines |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 24713374 |
| Type of Biomarker | Potential Diagnostic * |
| Pathway | Signaling pathways |
| Cohort | Human CC cell lines sarcomatoid SCK cells, three adenocarcinomatous cell lines, Choi-CK cell line , HCC cell lines HuH7, Hep3B, HepG2 cells |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Liver cancer |
| Year of Publication | 2014 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |